Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 11 09:32AM ET
103.34
Dollar change
+0.42
Percentage change
0.41
%
IndexDJIA, S&P 500 P/E21.64 EPS (ttm)4.77 Insider Own0.10% Shs Outstand2.53B Perf Week1.44%
Market Cap265.93B Forward P/E10.99 EPS next Y9.41 Insider Trans0.00% Shs Float2.53B Perf Month-5.82%
Income12.15B PEG0.91 EPS next Q1.85 Inst Own79.07% Short Float1.03% Perf Quarter-9.66%
Sales62.89B P/S4.23 EPS this Y412.98% Inst Trans1.12% Short Ratio2.84 Perf Half Y-20.07%
Book/sh17.58 P/B5.88 EPS next Y21.45% ROA10.83% Short Interest26.04M Perf Year0.94%
Cash/sh5.69 P/C18.17 EPS next 5Y23.85% ROE28.33% 52W Range98.60 - 134.63 Perf YTD-5.21%
Dividend Est.3.05 (2.95%) P/FCF17.92 EPS past 5Y-42.70% ROI15.28% 52W High-23.24% Beta0.41
Dividend TTM3.08 (2.98%) Quick Ratio1.15 Sales past 5Y7.72% Gross Margin73.03% 52W Low4.81% ATR (14)1.89
Dividend Ex-DateSep 16, 2024 Current Ratio1.36 EPS Y/Y TTM163.70% Oper. Margin23.00% RSI (14)38.80 Volatility1.69% 1.74%
Employees72000 Debt/Eq0.86 Sales Y/Y TTM8.17% Profit Margin19.32% Recom1.58 Target Price131.16
Option/ShortYes / Yes LT Debt/Eq0.79 EPS Q/Q-33.34% Payout2065.60% Rel Volume0.41 Prev Close102.92
Sales Surprise1.11% EPS Surprise5.80% Sales Q/Q4.42% EarningsOct 31 BMO Avg Volume9.18M Price103.34
SMA20-1.50% SMA50-6.42% SMA200-14.99% Trades Volume208,879 Change0.41%
Date Action Analyst Rating Change Price Target Change
TodayDowngrade Daiwa Securities Buy → Neutral
Oct-17-24Initiated Bernstein Mkt Perform $115
Mar-11-24Downgrade Societe Generale Hold → Sell $104
Jan-04-24Upgrade TD Cowen Market Perform → Outperform $125 → $135
Nov-09-23Initiated Deutsche Bank Buy $115
Oct-27-23Upgrade BMO Capital Markets Market Perform → Outperform $132
Oct-20-23Upgrade UBS Neutral → Buy $117 → $122
Jul-14-23Initiated HSBC Securities Hold $123
Apr-13-23Upgrade Citigroup Neutral → Buy $105 → $130
Mar-28-23Downgrade Societe Generale Buy → Hold
Nov-09-24 10:41AM
Nov-08-24 02:47PM
11:23AM
09:36AM
09:00AM
10:36AM Loading…
Nov-07-24 10:36AM
07:00AM
Nov-06-24 06:45AM
Nov-04-24 06:41PM
Nov-01-24 02:33PM
03:08AM
01:55AM
Oct-31-24 04:12PM
02:03PM
01:15PM
10:03AM Loading…
10:03AM
07:09AM
06:37AM
06:35AM
06:30AM
06:30AM
Oct-30-24 12:44PM
01:29AM
Oct-28-24 12:45PM
06:45AM
Oct-27-24 08:58AM
01:39AM
Oct-25-24 06:47PM
04:15PM
Oct-24-24 02:46PM
01:42PM Loading…
01:42PM
01:25PM
10:01AM
09:00AM
06:45AM
Oct-23-24 07:58PM
03:35PM
10:06AM
07:45AM
Oct-22-24 05:50PM
Oct-21-24 12:28PM
Oct-20-24 03:00PM
Oct-19-24 05:09PM
11:57AM
Oct-18-24 04:46PM
03:25PM
08:08AM
03:20AM
Oct-17-24 06:34PM
06:00PM
01:41PM
Oct-16-24 04:21PM
06:45AM
02:00AM
Oct-15-24 06:09PM
05:50PM
Oct-14-24 08:27AM
08:00AM
Oct-12-24 12:37PM
Oct-11-24 09:00AM
08:38AM
Oct-10-24 10:57AM
Oct-09-24 11:21AM
06:45AM
05:30AM
Oct-08-24 03:44PM
06:45AM
Oct-07-24 06:33AM
Oct-06-24 03:36PM
Oct-04-24 09:40AM
Oct-03-24 08:30AM
08:30AM
Oct-01-24 06:45AM
06:30AM
Sep-30-24 12:30PM
04:50AM
Sep-29-24 06:28AM
Sep-27-24 12:09PM
06:38AM
Sep-26-24 12:23PM
06:45AM
04:27AM
Sep-25-24 03:54PM
08:32AM
06:45AM
06:30AM
12:11AM
Sep-24-24 08:06AM
Sep-20-24 10:48AM
09:00AM
07:30AM
Sep-19-24 09:00AM
Sep-18-24 02:45PM
06:45AM
04:52AM
Sep-17-24 07:58AM
07:51AM
06:00AM
Sep-16-24 07:00AM
Sep-15-24 10:30AM
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Guindo ChirfiChief Marketing OfficerAug 05 '24Option Exercise115.2036,9014,250,99557,782Aug 06 12:20 PM
Smart DaltonSVP Fin. - Global ControllerMay 03 '24Option Exercise128.262,046262,4204,708May 06 04:10 PM
Smart DaltonSVP Fin. - Global ControllerMay 04 '24Option Exercise127.5161278,0364,730May 06 04:10 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthMay 04 '24Option Exercise127.5127,1263,458,836163,720May 06 04:08 PM
Klobuchar Michael AEVP - Chief Strategy OfficerMay 04 '24Option Exercise127.51887113,10124,058May 06 04:06 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketMay 04 '24Option Exercise127.51912116,28924,271May 06 04:01 PM
Romanelli JosephPresident, Human Health Int?lMay 02 '24Option Exercise128.802,262291,34621,831May 02 04:29 PM
Smart DaltonSVP Fin. - Global ControllerMay 02 '24Option Exercise128.8038149,0733,048May 02 04:23 PM
Merck & Co., Inc.10% OwnerMar 11 '24Buy23.0021,397,205492,135,7151,000Mar 11 03:27 PM
Litchfield CarolineEVP & CFOFeb 14 '24Option Exercise58.0838,2912,223,94189,199Feb 15 04:03 PM
Litchfield CarolineEVP & CFOFeb 14 '24Sale125.5038,2914,805,52050,908Feb 15 04:03 PM
Davis Robert MChairman, CEO & PresidentFeb 13 '24Option Exercise74.18150,00011,127,160498,327Feb 15 04:01 PM
Davis Robert MChairman, CEO & PresidentFeb 14 '24Option Exercise73.7385,0216,268,598433,348Feb 15 04:01 PM
Davis Robert MChairman, CEO & PresidentFeb 13 '24Sale125.85150,00018,877,424348,327Feb 15 04:01 PM
Davis Robert MChairman, CEO & PresidentFeb 14 '24Sale125.4085,02110,661,574348,327Feb 15 04:01 PM
Romanelli JosephPresident, Human Health Int?lFeb 13 '24Sale124.891,000124,88819,569Feb 14 04:03 PM
Li Dean YExecutive VP & President, MRLFeb 09 '24Option Exercise62.0714,702912,55360,944Feb 12 04:03 PM
Li Dean YExecutive VP & President, MRLFeb 09 '24Sale125.5014,7021,845,08346,242Feb 12 04:03 PM
Williams David MichaelEVP,Chief Info&Digital OfficerFeb 07 '24Sale127.571,451185,10819,812Feb 08 04:04 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 02 '24Option Exercise78.8020,9371,649,90642,286Feb 05 04:01 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 02 '24Sale127.1718,9592,411,11123,327Feb 05 04:01 PM
MIZELL STEVENEVP, Chief HR OfficerFeb 02 '24Option Exercise73.6532,9942,430,15974,313Feb 02 04:07 PM
MIZELL STEVENEVP, Chief HR OfficerFeb 02 '24Sale126.6550,6946,420,34923,619Feb 02 04:07 PM
Zachary JenniferEVP, General CounselFeb 02 '24Option Exercise87.1019,4171,691,22178,557Feb 02 04:05 PM
Zachary JenniferEVP, General CounselFeb 02 '24Sale126.9749,4996,284,77929,058Feb 02 04:05 PM